Protein (1)
Launched (1)
Human (1)
His Tag (1)
Unconjugated (1)
| Cat. No. | Species | Host | Product Description | Structure | Purity | Feature |
|---|---|---|---|---|---|---|
SPC-H52H3 | HEK293 | Human SPARC protein, His Tag (MALS verified) | ![]() |
| English Name | Research Code | Highest Development Stage | Company | Indication | Clinical Trial |
|---|---|---|---|---|---|
| Sonelokimab | ALX-0761; MSB-0010841; M-1095 | Phase 3 Clinical | Ablynx Nv | Psoriasis; Arthritis, Psoriatic; Hidradenitis Suppurativa | Details |
| Recombinant human IL-17A/F humanized antibody (Livzon Pharmaceutical Group) | LZM-012; LZM012; XKH004; XKH-004 | Phase 3 Clinical | Beijing Kanova Biomedical Technology Co Ltd, Livzon Pharmaceutical Group Inc | Spondylitis, Ankylosing; Psoriasis; Plaque psoriasis | Details |
| DMT-310 | DMT-310 | Phase 3 Clinical | Dermata | Acne Vulgaris; Rosacea | Details |
| HY-1770 | HY-1770; HT-17; HT17; YF02; HT25; GH02; HY1770 | Phase 1 Clinical | Suzhou Pharmavan Co Ltd | Plaque psoriasis; Dermatitis, Atopic | Details |





